Unique ID issued by UMIN | UMIN000046695 |
---|---|
Receipt number | R000053231 |
Scientific Title | Examination of stimulation brightness of multi-focal ERG recording without mydriasis (under non-mydriasis) |
Date of disclosure of the study information | 2022/01/21 |
Last modified on | 2022/01/21 17:47:45 |
Examination of stimulation brightness of multi-focal ERG recording without mydriasis (under non-mydriasis)
Examination of stimulation brightness of multi-focal ERG recording without mydriasis (under non-mydriasis)
Examination of stimulation brightness of multi-focal ERG recording without mydriasis (under non-mydriasis)
Examination of stimulation brightness of multi-focal ERG recording without mydriasis (under non-mydriasis)
Japan |
Normal eye
Ophthalmology |
Others
NO
We will examine the stimulus luminance for recording the same response as the conventional submydriatic mfERG under non-mydriasis.
Bio-equivalence
It was suggested that mfERG may be able to record the same response under mydriasis even under non-mydriasis by devising recording conditions. For the stimulation brightness under non-mydriasis, 1000 cd was considered to be the optimum intensity.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Prevention
Medicine |
Measure 5 times under non-mydriasis and 1 time under mydriasis.
When measuring under mydriasis, instill only one drop of Tropicamide, Phenylephrine Hydrochloride into the measuring eye.
Before measuring all 6 times, apply only one drop of Oxybuprocaine Hydrochloride to both eyes and then record.
22 | years-old | < |
61 | years-old | >= |
Male and Female
Employees working at the Osaka Medical Center who are 20 years of age or older at the time of obtaining consent.
Those who have no history of eye diseases other than systemic diseases and refractive errors.
Exclude those with a predisposition to increase intraocular pressure, such as glaucoma, narrow angle, and shallow anterior chamber.
Exclude those with a history of hypersensitivity to the components of the drugs used (Tropicamide, Phenylephrine Hydrochloride, Oxybuprocaine Hydrochloride ophthalmic solution) and benzoic acid ester-based local anesthetics.
10
1st name | Nakamura |
Middle name | |
Last name | Eiji |
National Hospital Organization Osaka National Hospital
Ophthalmology
5400006
2-1-14 Hoenzaka, Chuo-ku, Osaka
0669421331
eijin0314@gmail.com
1st name | Nakamura |
Middle name | |
Last name | Eiji |
National Hospital Organization Osaka National Hospital
Ophthalmology
5400006
2-1-14 Hoenzaka, Chuo-ku, Osaka
0669421331
eijin0314@gmail.com
National Hospital Organization Osaka National Hospital
none
Other
National Hospital Organization Osaka Medical Center Contract Research Review Committee Second Committee
2-1-14 Hoenzaka, Chuo-ku, Osaka
0669421331
408-chiken@mail.hosp.go.jp
NO
2022 | Year | 01 | Month | 21 | Day |
Published
10
Completed
2020 | Year | 11 | Month | 09 | Day |
2020 | Year | 11 | Month | 09 | Day |
2020 | Year | 11 | Month | 09 | Day |
2021 | Year | 12 | Month | 31 | Day |
2022 | Year | 01 | Month | 21 | Day |
2022 | Year | 01 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053231
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |